Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Intas Pharmaceuticals

    Client Virtual Booth

    INTAS PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Intas Pharmaceuticals
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad, Gujarat
    Telephone
    Telephone
    +91 79 6652 3100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://intaspharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/intas-pharmaceuticals/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Intas Pharmaceuticals is on FDA Import Alert List
    Intas Pharmaceuticals is on FDA Import Alert List

    https://www.accessdata.fda.gov/cms_ia/importalert_189.html

    FDA
    10 Apr 2024
    Share Share
    Intas inks agreement for treating autoimmune diseases in 150+ countries
    Intas inks agreement for treating autoimmune diseases in 150+ countries

    https://www.biospectrumasia.com/news/25/23499/indian-firm-intas-pharma-inks-new-licensing-agreement-for-treating-autoimmune-diseases-in-150-countries.html

    BIOSPECTRUM ASIA
    20 Dec 2023
    Share Share
    USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant
    USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-pulls-up-intas-pharma-for-manufacturing-lapses-at-ahmedabad-plant/articleshow/105873994.cms

    ECONOMIC TIMES
    10 Dec 2023
    Share Share
    FDA put Intas plant on import alert, warning letter shows
    FDA put Intas plant on import alert, warning letter shows

    https://www.fiercepharma.com/manufacturing/fda-slams-intas-data-manipulation-management-failures-warning-letter

    Zoey Becker FIERCE PHARMA
    29 Nov 2023
    Share Share
    Intas Pharmaceuticals Limited Receives FDA Warning Letter
    Intas Pharmaceuticals Limited Receives FDA Warning Letter

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intas-pharmaceuticals-limited-662868-11212023

    FDA
    28 Nov 2023
    Share Share
    Intas Pharmaceuticals Limited on FDA Import Alert List
    Intas Pharmaceuticals Limited on FDA Import Alert List

    https://www.accessdata.fda.gov/cms_ia/importalert_189.html

    FDA
    14 Nov 2023
    Share Share
    Henlius Deepens Collaboration with Intas to bring Serplulimab to Europe & India
    Henlius Deepens Collaboration with Intas to bring Serplulimab to Europe & India

    https://www.prnewswire.com/news-releases/henlius-deepens-collaboration-with-intas-to-bring-henlius-novel-anti-pd-1-mab-serplulimab-to-europe-and-india-301970103.html

    PR NEWSWIRE
    27 Oct 2023
    Share Share
    USFDA issues warning letter to Intas Pharma for Sanand plant
    USFDA issues warning letter to Intas Pharma for Sanand plant

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-letter-to-intas-pharma-for-sanand-plant/articleshow/102466930.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    06 Aug 2023
    Share Share
    Intas Pharmaceuticals Receives FDA Warning Letter
    Intas Pharmaceuticals Receives FDA Warning Letter

    https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intas-pharmaceuticals-limited-652067-07282023

    FDA
    01 Aug 2023
    Share Share
    FDA slams Intas, Ipca over manufacturing shortfalls at 3 plants
    FDA slams Intas, Ipca over manufacturing shortfalls at 3 plants

    https://www.fiercepharma.com/pharma/fda-slams-intas-ipca-trio-indian-manufacturing-write-ups

    Fraiser Kansteiner FIERCE PHARMA
    07 Jul 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search